More than 74,200 Victorians currently live with the hepatitis C virus. Previously, only 1.3% of people living with hepatitis C received treatment; left untreated, chronic hepatitis C can lead to liver failure, liver cancer and death. However, since March this year, several new direct acting antivirals to treat hepatitis C have been made available on the PBS General Schedule.
This means that these medications can now be prescribed by general practitioners and supplied by community pharmacies. As a result, more people with hepatitis C can be treated and cured. This session delivered by Victorian Infectious Diseases Specialist Dr Thomas Schulz and current community pharmacist Ms Dimitra Tsucalas, will assist pharmacists in the provision of hepatitis C medications and services in the primary care sector.
*This lecture will be broadcast to regional Primary Health Network Sites. For catering, please select the site you will be attending.
*This event is brought to you by the Pharmaceutical Society of Australia and Victorian PHN Alliance and is free for ALL Pharmacists.